LAS VEGAS, Sept. 18, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that Louisiana State University (LSU) AgCenter has posted comments on the recently finalized agreement between GB Sciences Louisiana LLC, a subsidiary of GB Sciences, and the LSUag Center.
To read LSU’s Press Release click on this link:
http://www.lsuagcenter.com/profiles/tblanchard/articles/page1505685314158
About GB Sciences, Inc.
GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.
Forward-Looking Statements
This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.
Note: Although the Company’s research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist.
Contact Information
Corporate:
GB Sciences, Inc., 3550 West Teco Ave., Las Vegas, NV 89118
866-721-0297, or
Liz Bianco Publicity Director, liz@gbsciences.com, http://gbsciences.com
Tom Arcuragi, COO, tom@gbsciences.com
View original content with multimedia:http://www.prnewswire.com/news-releases/groundbreaking-collaboration-between-a-major-university-and-a-medical-cannabis-company-300521325.html
SOURCE GB Sciences, Inc.
